Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Piyathilake CJ et al. – Higher levels of Lys–9 methylation in >=CIN 2 compared to <=CIN 1 lesions suggest that higher Lys–9 methylation is associated with progression of lower grade CIN to higher grade CIN. Higher Lys–9 methylation in cervical tissues of women diagnosed with CIN 3 in the postfortification period than in pre–fortification period suggest that fortification may adversely affect histone methylation in already initiated cells. Lower Lys–9 methylation in normal/reactive cervical cells of women free of CIN in the post–fortification period than pre–fortification on the other hand suggests that fortification is likely to protect against initiation of carcinogenic process in the cervix. These results suggest that mandatory fortification with folic acid in the US seems to have different effects on cancer depending on the stage of carcinogenesis. Because this is the first study to report folic acid fortification–associated differences in histone methylation and because of the limitations inherent to the approach the authors have taken to demonstrate these differences, validation of the results in other study populations or with other techniques for assessing histone methylation is necessary.

Related Articles

Cancer incidence and mortality after treatment with folic acid and Vitamin B12
JAMA, 11/18/09    Relevance Score: 71%

A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09    Relevance Score: 71%

Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2006
American Journal of Clinical Nutrition, 10/15/09    Relevance Score: 71%

Folic acid fortification: a double-edged sword
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09    Relevance Score: 70%

Different Doses of Oral Folic Acid for Homocysteine-Lowering Therapy in Patients on Hemodialysis: A Randomized Controlled Trial
Iranian Journal of Kidney Diseases, 10/13/09    Relevance Score: 69%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address